🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate the Pharmacokinetic (PK) and safety of Budesoni...
Status
Completed
Location
Research Site
Start Date
2023-11-16
Trial ID
NCT06139991
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter, parall...
Status
Completed
Location
Research Site
Start Date
2019-03-20
Trial ID
NCT03847896
Treatments Being Tested
This study is to compare the systemic exposure of budesonide delivered by t...
Status
Completed
Location
Research Site
Start Date
2019-05-16
Trial ID
NCT03934333
Treatments Being Tested
This is a Phase 1 study to compare the pharmacokinetics of budesonide and a...
Status
Completed
Location
Research Site
Start Date
2019-01-21
Trial ID
NCT03772223
The purpose of this study is to compare the effect of budesonide/albuterol ...
Status
Recruiting
Location
Research Site
Start Date
2024-05-20
Trial ID
NCT06307665
This is a randomized, double-blind, multicenter, parallel-group, variable-l...
Status
Completed
Location
Research Site
Start Date
2018-12-13
Trial ID
NCT03769090
To compare the pharmacokinetics of budesonide delivered by BDA MDI to budes...
Status
Completed
Location
IPS Research
Start Date
2021-05-06
Trial ID
NCT04848662
Treatments Being Tested
The purpose of this Phase III, multicentre, randomized, double-blind, singl...
Status
Completed
Location
Research Site
Start Date
2023-12-22
Trial ID
NCT06245551
Treatments Being Tested
The purpose of this study is to assess the PD equivalence of the approved a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-07-22
Trial ID
NCT06502366
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of albutero...
Status
Completed
Location
Research Site
Start Date
2024-09-11
Trial ID
NCT06563102
Treatments Being Tested